Animal models to study cancer-initiating cells from Glioblastoma

Frontiers in Bioscience

Volumn 16, Issue 6, 2011, Pages 2243-2258

  Wee, Boyoung ^a   Charles, Nikki ^a   Holland, Eric C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brain tumor initiating cell; Cancer stem cell; Genetic alterations; Glioblastoma multiforme; Microenvironment; Murine model; Review

Indexed keywords

ANIMALIA; MURINAE;

ANIMAL; BIOLOGICAL MODEL; BRAIN TUMOR; CANCER STEM CELL; DISEASE MODEL; GENE TRANSFER; GLIOBLASTOMA; HUMAN; MOUSE; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE;

ANIMALS; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MUTATION; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 79959722617     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3851     Document Type: Review

References (106)

1. R. Stupp, W. P. Mason, M. J. van den Bent, M. Weller, B. Fisher, M. J. Taphoorn, K. Belanger, A. A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R. C. Janzer, S. K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J. G. Cairncross, E. Eisenhauer and R. O. Mirimanoff: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 352(10), 987-96 (2005) (Pubitemid 40349501)
2. D. A. Reardon, J. N. Rich, H. S. Friedman and D. D. Bigner: Recent advances in the treatment of malignant astrocytoma. J Clin Oncol, 24(8), 1253-65 (2006) (Pubitemid 46622028)
3. P. Dalerba, R. W. Cho and M. F. Clarke: Cancer stem cells: models and concepts. Annu Rev Med, 58, 267-84 (2007) (Pubitemid 46706514)
4. D. Bonnet and J. E. Dick: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 3(7), 730-7 (1997) (Pubitemid 27298715)
5. N. J. Msaitland, S. D. Bryce, M. J. Stower and A. T. Collins: Prostate cancer stem cells: a target for new therapies. Ernst Schering Found Symp Proc(5), 155-79 (2006)
6. M. E. Prince, R. Sivanandan, A. Kaczorowski, G. T. Wolf, M. J. Kaplan, P. Dalerba, I. L. Weissman, M. F. Clarke and L. E. Ailles: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A, 104(3), 973-8 (2007) (Pubitemid 46154721)
7. C. Li, D. G. Heidt, P. Dalerba, C. F. Burant, L. Zhang, V. Adsay, M. Wicha, M. F. Clarke and D. M. Simeone: Identification of pancreatic cancer stem cells. Cancer Res, 67(3), 1030-7 (2007)
8. C. A. O'Brien, A. Pollett, S. Gallinger and J. E. Dick: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445(7123), 106-10 (2007) (Pubitemid 46067310)
9. T. N. Ignatova, V. G. Kukekov, E. D. Laywell, O. N. Suslov, F. D. Vrionis and D. A. Steindler: Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia, 39(3), 193-206 (2002)
10. H. D. Hemmati, I. Nakano, J. A. Lazareff, M. Masterman-Smith, D. H. Geschwind, M. Bronner-Fraser and H. I. Kornblum: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A, 100(25), 15178-83 (2003) (Pubitemid 37518036)
11. T. Reya, S. J. Morrison, M. F. Clarke and I. L. Weissman: Stem cells, cancer, and cancer stem cells. Nature, 414(6859), 105-11 (2001) (Pubitemid 33041634)
12. S. K. Singh, C. Hawkins, I. D. Clarke, J. A. Squire, J. Bayani, T. Hide, R. M. Henkelman, M. D. Cusimano and P. B. Dirks: Identification of human brain tumour initiating cells. Nature, 432(7015), 396-401 (2004) (Pubitemid 39551674)
13. R. Galli, E. Binda, U. Orfanelli, B. Cipelletti, A. Gritti, S. De Vitis, R. Fiocco, C. Foroni, F. Dimeco and A. Vescovi: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res, 64(19), 7011-21 (2004) (Pubitemid 39331011)
14. T. Kondo, T. Setoguchi and T. Taga: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A, 101(3), 781-6 (2004) (Pubitemid 38121035)
15. M. Dean, T. Fojo and S. Bates: Tumour stem cells and drug resistance. Nat Rev Cancer, 5(4), 275-84 (2005) (Pubitemid 40488633)
16. E. C. Holland: Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet, 2(2), 120-9 (2001) (Pubitemid 33674003)
17. J. T. Huse and E. C. Holland: Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer, 10(5), 319-31 (2010)
18. J. N. Rich, C. Guo, R. E. McLendon, D. D. Bigner, X. F. Wang and C. M. Counter: A genetically tractable model of human glioma formation. Cancer Res, 61(9), 3556-60 (2001) (Pubitemid 32694959)
19. Y. Sonoda, T. Ozawa, Y. Hirose, K. D. Aldape, M. McMahon, M. S. Berger and R. O. Pieper: Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res, 61(13), 4956-60 (2001) (Pubitemid 32681517)
20. R. M. Bachoo, E. A. Maher, K. L. Ligon, N. E. Sharpless, S. S. Chan, M. J. You, Y. Tang, J. DeFrances, E. Stover, R. Weissleder, D. H. Rowitch, D. N. Louis and R. A. DePinho: Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell, 1(3), 269-77 (2002) (Pubitemid 41039151)
21. H. Ding, P. Shannon, N. Lau, X. Wu, L. Roncari, R. L. Baldwin, H. Takebayashi, A. Nagy, D. H. Gutmann and A. Guha: Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model. Cancer Res, 63(5), 1106-13 (2003) (Pubitemid 36278445)
22. W. A. Weiss, M. J. Burns, C. Hackett, K. Aldape, J. R. Hill, H. Kuriyama, N. Kuriyama, N. Milshteyn, T. Roberts, M. F. Wendland, R. DePinho and M. A. Israel: Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res, 63(7), 1589-95 (2003) (Pubitemid 36373648)
23. L. Uhrbom, M. Kastemar, F. K. Johansson, B. Westermark and E. C. Holland: Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis. Cancer Res, 65(6), 2065-9 (2005) (Pubitemid 40490109)
24. A. Xiao, C. Yin, C. Yang, A. Di Cristofano, P. P. Pandolfi and T. Van Dyke: Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation. Cancer Res, 65(12), 5172-80 (2005) (Pubitemid 40827326)
25. A. B. Lassman, C. Dai, G. N. Fuller, A. J. Vickers and E. C. Holland: Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice. Neuron Glia Biol, 1(2), 157-63 (2004)
26. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455(7216), 1061-8 (2008)
27. D. W. Parsons, S. Jones, X. Zhang, J. C. Lin, R. J. Leary, P. Angenendt, P. Mankoo, H. Carter, I. M. Siu, G. L. Gallia, A. Olivi, R. McLendon, B. A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D. A. Busam, H. Tekleab, L. A. Diaz, Jr., J. Hartigan, D. R. Smith, R. L. Strausberg, S. K. Marie, S. M. Shinjo, H. Yan, G. J. Riggins, D. D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. E. Velculescu and K. W. Kinzler: An integrated genomic analysis of human glioblastoma multiforme. Science, 321(5897), 1807-12 (2008)
28. G. J. Spangrude, S. Heimfeld and I. L. Weissman: Purification and characterization of mouse hematopoietic stem cells. Science, 241(4861), 58-62 (1988)
29. T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, J. Caceres-Cortes, M. Minden, B. Paterson, M. A. Caligiuri and J. E. Dick: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367(6464), 645-8 (1994) (Pubitemid 24067706)
30. M. J. Son, K. Woolard, D. H. Nam, J. Lee and H. A. Fine: SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell, 4(5), 440-52 (2009)
31. V. Clement, D. Marino, C. Cudalbu, M. F. Hamou, V. Mlynarik, N. de Tribolet, P. Y. Dietrich, R. Gruetter, M. E. Hegi and I. Radovanovic: Marker-independent identification of glioma-initiating cells. Nat Methods, 7(3), 224-8 (2010)
32. J. Lee, S. Kotliarova, Y. Kotliarov, A. Li, Q. Su, N. M. Donin, S. Pastorino, B. W. Purow, N. Christopher, W. Zhang, J. K. Park and H. A. Fine: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell, 9(5), 391-403 (2006) (Pubitemid 43668737)
33. S. K. Singh, I. D. Clarke, M. Terasaki, V. E. Bonn, C. Hawkins, J. Squire and P. B. Dirks: Identification of a cancer stem cell in human brain tumors. Cancer Res, 63(18), 5821-8 (2003) (Pubitemid 37187480)
34. X. Yuan, J. Curtin, Y. Xiong, G. Liu, S. Waschsmann- Hogiu, D. L. Farkas, K. L. Black and J. S. Yu: Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene, 23(58), 9392-400 (2004) (Pubitemid 40069671)
35. D. Beier, P. Hau, M. Proescholdt, A. Lohmeier, J. Wischhusen, P. J. Oefner, L. Aigner, A. Brawanski, U. Bogdahn and C. P. Beier: CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res, 67(9), 4010-5 (2007) (Pubitemid 46815044)
36. J. Wang, P. O. Sakariassen, O. Tsinkalovsky, H. Immervoll, S. O. Boe, A. Svendsen, L. Prestegarden, G. Rosland, F. Thorsen, L. Stuhr, A. Molven, R. Bjerkvig and P. O. Enger: CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer, 122(4), 761-8 (2008)
37. A. T. Ogden, A. E. Waziri, R. A. Lochhead, D. Fusco, K. Lopez, J. A. Ellis, J. Kang, M. Assanah, G. M. McKhann, M. B. Sisti, P. C. McCormick, P. Canoll and J. N. Bruce: Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery, 62(2), 505-14; discussion 514-5 (2008) (Pubitemid 351489297)
38. J. X. Cheng, B. L. Liu and X. Zhang: How powerful is CD133 as a cancer stem cell marker in brain tumors? Cancer Treat Rev, 35(5), 403-8 (2009)
39. A. Capela and S. Temple: LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron, 35(5), 865-75 (2002)
40. A. M. Bleau, D. Hambardzumyan, T. Ozawa, E. I. Fomchenko, J. T. Huse, C. W. Brennan and E. C. Holland: PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell, 4(3), 226-35 (2009)
41. Y. Jin, Z. Q. Bin, H. Qiang, C. Liang, C. Hua, D. Jun, W. A. Dong and L. Qing: ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma. J Cancer Res Clin Oncol, 135(10), 1369-76 (2009)
42. M. A. Goodell, K. Brose, G. Paradis, A. S. Conner and R. C. Mulligan: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med, 183(4), 1797-806 (1996) (Pubitemid 26134320)
43. C. Lois and A. Alvarez-Buylla: Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A, 90(5), 2074-7 (1993) (Pubitemid 23070000)
44. D. S. Currle and R. J. Gilbertson: The niche revealed. Cell Stem Cell, 3(3), 234-6 (2008)
45. Q. Shen, S. K. Goderie, L. Jin, N. Karanth, Y. Sun, N. Abramova, P. Vincent, K. Pumiglia and S. Temple: Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science, 304(5675), 1338-40 (2004) (Pubitemid 38697433)
46. C. Ramirez-Castillejo, F. Sanchez-Sanchez, C. Andreu- Agullo, S. R. Ferron, J. D. Aroca-Aguilar, P. Sanchez, H. Mira, J. Escribano and I. Farinas: Pigment epitheliumderived factor is a niche signal for neural stem cell renewal. Nat Neurosci, 9(3), 331-9 (2006) (Pubitemid 43290962)
47. C. Calabrese, H. Poppleton, M. Kocak, T. L. Hogg, C. Fuller, B. Hamner, E. Y. Oh, M. W. Gaber, D. Finklestein, M. Allen, A. Frank, I. T. Bayazitov, S. S. Zakharenko, A. Gajjar, A. Davidoff and R. J. Gilbertson: A perivascular niche for brain tumor stem cells. Cancer Cell, 11(1), 69-82 (2007) (Pubitemid 46054518)
48. N. Charles, T. Ozawa, M. Squatrito, A. M. Bleau, C. W. Brennan, D. Hambardzumyan and E. C. Holland: Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell, 6(2), 141-52 (2010)
49. C. S. Cobbs, J. E. Brenman, K. D. Aldape, D. S. Bredt and M. A. Israel: Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res, 55(4), 727-30 (1995)
50. D. Fukumura, S. Kashiwagi and R. K. Jain: The role of nitric oxide in tumour progression. Nat Rev Cancer, 6(7), 521-34 (2006) (Pubitemid 43980541)
51. S. Hitoshi, T. Alexson, V. Tropepe, D. Donoviel, A. J. Elia, J. S. Nye, R. A. Conlon, T. W. Mak, A. Bernstein and D. van der Kooy: Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev, 16(7), 846-58 (2002) (Pubitemid 34280108)
52. B. W. Purow, R. M. Haque, M. W. Noel, Q. Su, M. J. Burdick, J. Lee, T. Sundaresan, S. Pastorino, J. K. Park, I. Mikolaenko, D. Maric, C. G. Eberhart and H. A. Fine: Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res, 65(6), 2353-63 (2005) (Pubitemid 40490146)
53. P. Xu, S. Yu, R. Jiang, C. Kang, G. Wang, H. Jiang and P. Pu: Differential expression of Notch family members in astrocytomas and medulloblastomas. Pathol Oncol Res, 15(4), 703-10 (2009)
54. A. H. Shih and E. C. Holland: Notch signaling enhances nestin expression in gliomas. Neoplasia, 8(12), 1072-82 (2006) (Pubitemid 44936157)
55. N. Dahmane, P. Sanchez, Y. Gitton, V. Palma, T. Sun, M. Beyna, H. Weiner and A. Ruiz i Altaba: The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development, 128(24), 5201-12 (2001) (Pubitemid 34083045)
56. M. Ehtesham, A. Sarangi, J. G. Valadez, S. Chanthaphaychith, M. W. Becher, T. W. Abel, R. C. Thompson and M. K. Cooper: Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells. Oncogene, 26(39), 5752-61 (2007) (Pubitemid 47312811)
57. E. E. Bar, A. Chaudhry, A. Lin, X. Fan, K. Schreck, W. Matsui, S. Piccirillo, A. L. Vescovi, F. DiMeco, A. Olivi and C. G. Eberhart: Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells, 25(10), 2524-33 (2007) (Pubitemid 47582744)
58. V. Clement, P. Sanchez, N. de Tribolet, I. Radovanovic and A. Ruiz i Altaba: HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell selfrenewal, and tumorigenicity. Curr Biol, 17(2), 165-72 (2007) (Pubitemid 46107823)
59. N. Yamada, M. Kato, P. ten Dijke, H. Yamashita, T. K. Sampath, C. H. Heldin, K. Miyazono and K. Funa: Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours. Br J Cancer, 73(5), 624-9 (1996) (Pubitemid 26068867)
60. S. G. Piccirillo, B. A. Reynolds, N. Zanetti, G. Lamorte, E. Binda, G. Broggi, H. Brem, A. Olivi, F. Dimeco and A. L. Vescovi: Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumourinitiating cells. Nature, 444(7120), 761-5 (2006) (Pubitemid 44949605)
61. F. Yang, C. Brown, R. Buettner, M. Hedvat, R. Starr, A. Scuto, A. Schroeder, M. Jensen and R. Jove: Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3. Mol Cancer Ther, 9(4), 953-62 (2010)
62. C. Choi, G. Y. Gillespie, N. J. Van Wagoner and E. N. Benveniste: Fas engagement increases expression of interleukin-6 in human glioma cells. J Neurooncol, 56(1), 13-9 (2002) (Pubitemid 34256613)
63. A. Tchirkov, T. Khalil, E. Chautard, K. Mokhtari, L. Veronese, B. Irthum, P. Vago, J. L. Kemeny and P. Verrelle: Interleukin-6 gene amplification and shortened survival in glioblastoma patients. Br J Cancer, 96(3), 474-6 (2007) (Pubitemid 46215219)
64. H. Wang, J. D. Lathia, Q. Wu, J. Wang, Z. Li, J. M. Heddleston, C. E. Eyler, J. Elderbroom, J. Gallagher, J. Schuschu, J. MacSwords, Y. Cao, R. E. McLendon, X. F. Wang, A. B. Hjelmeland and J. N. Rich: Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells, 27(10), 2393-404 (2009)
65. S. Bao, Q. Wu, S. Sathornsumetee, Y. Hao, Z. Li, A. B. Hjelmeland, Q. Shi, R. E. McLendon, D. D. Bigner and J. N. Rich: Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res, 66(16), 7843-8 (2006) (Pubitemid 44299144)
66. J. D. Lathia, J. Gallagher, J. M. Heddleston, J. Wang, C. E. Eyler, J. Macswords, Q. Wu, A. Vasanji, R. E. McLendon, A. B. Hjelmeland and J. N. Rich: Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell, 6(5), 421-32 (2010)
67. A. O. Perantoni, J. M. Rice, C. D. Reed, M. Watatani and M. L. Wenk: Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosourea. Proc Natl Acad Sci U S A, 84(17), 6317-21 (1987)
68. D. M. Kokkinakis, M. L. Watson, L. S. Honig, E. J. Rushing, B. E. Mickey and S. C. Schold, Jr.: Characterization of initiated cells in N-methylnitrosoureainduced carcinogenesis of the CNS in the adult rat. Neuro Oncol, 3(2), 99-112 (2001) (Pubitemid 33691767)
69. W. R. Shapiro, G. A. Basler, N. L. Chernik and J. B. Posner: Human brain tumor transplantation into nude mice. J Natl Cancer Inst, 62(3), 447-53 (1979) (Pubitemid 9122379)
70. N. Kobayashi, N. Allen, N. R. Clendenon and L. W. Ko: An improved rat brain-tumor model. J Neurosurg, 53(6), 808-15 (1980) (Pubitemid 11194442)
71. M. Westphal, M. Hansel, W. Hamel, R. Kunzmann and F. Holzel: Karyotype analyses of 20 human glioma cell lines. Acta Neurochir (Wien), 126(1), 17-26 (1994) (Pubitemid 24027537)
72. L. Antunes, K. Angioi-Duprez, S. R. Bracard, N. A. Klein-Monhoven, A. E. Le Faou, A. M. Duprez and F. M. Plenat: Analysis of tissue chimerism in nude mouse brain and abdominal xenograft models of human glioblastoma multiforme: What does it tell us about the models and about glioblastoma biology and therapy? Journal of Histochemistry & Cytochemistry, 48(6), 847-858 (2000) (Pubitemid 30366619)
73. L. Uhrbom, G. Hesselager, M. Nister and B. Westermark: Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res, 58(23), 5275-9 (1998) (Pubitemid 28551098)
74. E. C. Holland, W. P. Hively, R. A. DePinho and H. E. Varmus: A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cellcycle arrest pathways to induce glioma-like lesions in mice. Genes Dev, 12(23), 3675-85 (1998) (Pubitemid 29019648)
75. E. C. Holland, W. P. Hively, V. Gallo and H. E. Varmus: Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes. Genes Dev, 12(23), 3644-9 (1998) (Pubitemid 29019645)
76. C. Raffel, R. B. Jenkins, L. Frederick, D. Hebrink, B. Alderete, D. W. Fults and C. D. James: Sporadic medulloblastomas contain PTCH mutations. Cancer Res, 57(5), 842-5 (1997) (Pubitemid 27098006)
77. S. H. Hughes, J. J. Greenhouse, C. J. Petropoulos and P. Sutrave: Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J Virol, 61(10), 3004-12 (1987) (Pubitemid 17131484)
78. P. Bates, J. A. Young and H. E. Varmus: A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell, 74(6), 1043-51 (1993) (Pubitemid 23289461)
79. J. A. Young, P. Bates and H. E. Varmus: Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses. J Virol, 67(4), 1811-6 (1993) (Pubitemid 23088352)
80. G. H. Fisher, S. Orsulic, E. Holland, W. P. Hively, Y. Li, B. C. Lewis, B. O. Williams and H. E. Varmus: Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene, 18(38), 5253-60 (1999) (Pubitemid 29462360)
81. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S. I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S. H. Bigner, B. C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M. H. Wigler and R. Parsons: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275(5308), 1943-7 (1997) (Pubitemid 27148818)
82. T. Sano, H. Lin, X. Chen, L. A. Langford, D. Koul, M. L. Bondy, K. R. Hess, J. N. Myers, Y. K. Hong, W. K. Yung and P. A. Steck: Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res, 59(8), 1820-4 (1999) (Pubitemid 29186149)
83. A. Di Cristofano, B. Pesce, C. Cordon-Cardo and P. P. Pandolfi: Pten is essential for embryonic development and tumour suppression. Nat Genet, 19(4), 348-55 (1998) (Pubitemid 28357906)
84. A. Suzuki, J. L. de la Pompa, V. Stambolic, A. J. Elia, T. Sasaki, I. del Barco Barrantes, A. Ho, A. Wakeham, A. Itie, W. Khoo, M. Fukumoto and T. W. Mak: High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol, 8(21), 1169-78 (1998) (Pubitemid 28494715)
85. K. Podsypanina, L. H. Ellenson, A. Nemes, J. Gu, M. Tamura, K. M. Yamada, C. Cordon-Cardo, G. Catoretti, P. E. Fisher and R. Parsons: Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A, 96(4), 1563-8 (1999) (Pubitemid 29098491)
86. L. Uhrbom, C. Dai, J. C. Celestino, M. K. Rosenblum, G. N. Fuller and E. C. Holland: Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res, 62(19), 5551-8 (2002)
87. X. Hu, P. P. Pandolfi, Y. Li, J. A. Koutcher, M. Rosenblum and E. C. Holland: mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia, 7(4), 356-68 (2005) (Pubitemid 40664225)
88. C. Dai, J. C. Celestino, Y. Okada, D. N. Louis, G. N. Fuller and E. C. Holland: PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev, 15(15), 1913-25 (2001) (Pubitemid 32738621)
89. S. Alcantara Llaguno, J. Chen, C. H. Kwon, E. L. Jackson, Y. Li, D. K. Burns, A. Alvarez-Buylla and L. F. Parada: Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell, 15(1), 45-56 (2009)
90. H. Zhu, J. Acquaviva, P. Ramachandran, A. Boskovitz, S. Woolfenden, R. Pfannl, R. T. Bronson, J. W. Chen, R. Weissleder, D. E. Housman and A. Charest: Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis. Proc Natl Acad Sci U S A, 106(8), 2712-6 (2009)
91. K. M. Reilly, D. A. Loisel, R. T. Bronson, M. E. McLaughlin and T. Jacks: Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat Genet, 26(1), 109-13 (2000)
92. B. Sauer: Inducible gene targeting in mice using the Cre/lox system. Methods, 14(4), 381-92 (1998)
93. Y. Zhu, F. Guignard, D. Zhao, L. Liu, D. K. Burns, R. P. Mason, A. Messing and L. F. Parada: Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell, 8(2), 119-30 (2005) (Pubitemid 41132741)
94. C. H. Kwon, D. Zhao, J. Chen, S. Alcantara, Y. Li, D. K. Burns, R. P. Mason, E. Y. Lee, H. Wu and L. F. Parada: Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res, 68(9), 3286-94 (2008)
95. Q. Wei, L. Clarke, D. K. Scheidenhelm, B. Qian, A. Tong, N. Sabha, Z. Karim, N. A. Bock, R. Reti, R. Swoboda, E. Purev, J. F. Lavoie, M. L. Bajenaru, P. Shannon, D. Herlyn, D. Kaplan, R. M. Henkelman, D. H. Gutmann and A. Guha: High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model. Cancer Res, 66(15), 7429-37 (2006) (Pubitemid 44289195)
96. A. Xiao, H. Wu, P. P. Pandolfi, D. N. Louis and T. Van Dyke: Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell, 1(2), 157-68 (2002) (Pubitemid 41039162)
97. T. Kondo and M. Raff: Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science, 289(5485), 1754-7 (2000)
98. E. L. Jackson, J. M. Garcia-Verdugo, S. Gil-Perotin, M. Roy, A. Quinones-Hinojosa, S. VandenBerg and A. Alvarez- Buylla: PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron, 51(2), 187-99 (2006) (Pubitemid 44063617)
99. F. Doetsch, I. Caille, D. A. Lim, J. M. Garcia-Verdugo and A. Alvarez-Buylla: Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell, 97(6), 703-16 (1999) (Pubitemid 29278045)
100. D. Hambardzumyan, N. M. Amankulor, K. Y. Helmy, O. J. Becher and E. C. Holland: Modeling Adult Gliomas Using RCAS/t-va Technology. Transl Oncol, 2(2), 89-95 (2009)
101. S. Godard, G. Getz, M. Delorenzi, P. Farmer, H. Kobayashi, I. Desbaillets, M. Nozaki, A. C. Diserens, M. F. Hamou, P. Y. Dietrich, L. Regli, R. C. Janzer, P. Bucher, R. Stupp, N. de Tribolet, E. Domany and M. E. Hegi: Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res, 63(20), 6613-25 (2003) (Pubitemid 37322939)
102. C. L. Nutt, D. R. Mani, R. A. Betensky, P. Tamayo, J. G. Cairncross, C. Ladd, U. Pohl, C. Hartmann, M. E. McLaughlin, T. T. Batchelor, P. M. Black, A. von Deimling, S. L. Pomeroy, T. R. Golub and D. N. Louis: Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res, 63(7), 1602-7 (2003) (Pubitemid 36373650)
103. H. S. Phillips, S. Kharbanda, R. Chen, W. F. Forrest, R. H. Soriano, T. D. Wu, A. Misra, J. M. Nigro, H. Colman, L. Soroceanu, P. M. Williams, Z. Modrusan, B. G. Feuerstein and K. Aldape: Molecular subclasses of highgrade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell, 9(3), 157-73 (2006) (Pubitemid 43357943)
104. I. K. Mellinghoff, M. Y. Wang, I. Vivanco, D. A. Haas-Kogan, S. Zhu, E. Q. Dia, K. V. Lu, K. Yoshimoto, J. H. Huang, D. J. Chute, B. L. Riggs, S. Horvath, L. M. Liau, W. K. Cavenee, P. N. Rao, R. Beroukhim, T. C. Peck, J. C. Lee, W. R. Sellers, D. Stokoe, M. Prados, T. F. Cloughesy, C. L. Sawyers and P. S. Mischel: Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med, 353(19), 2012-24 (2005) (Pubitemid 41609094)
105. X. Fan, L. Khaki, T. S. Zhu, M. E. Soules, C. E. Talsma, N. Gul, C. Koh, J. Zhang, Y. M. Li, J. Maciaczyk, G. Nikkhah, F. Dimeco, S. Piccirillo, A. L. Vescovi and C. G. Eberhart: NOTCH pathway blockade depletes CD133- positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells, 28(1), 5-16 (2010)
106. J. Wang, T. P. Wakeman, J. D. Lathia, A. B. Hjelmeland, X. F. Wang, R. R. White, J. N. Rich and B. A. Sullenger: Notch promotes radioresistance of glioma stem cells. Stem Cells, 28(1), 17-28 (2010)